- Home
- ELVA vs MIST Comparison
ELVA vs MIST Comparison
Compare ELVA & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVA
- MIST
- Stock Information
- Founded
- ELVA 1996
- MIST 2003
- Country
- ELVA Canada
- MIST Canada
- Employees
- ELVA N/A
- MIST N/A
- Industry
- ELVA
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- ELVA
- MIST Health Care
- Exchange
- ELVA Nasdaq
- MIST Nasdaq
- Market Cap
- ELVA 125.5M
- MIST 145.3M
- IPO Year
- ELVA N/A
- MIST N/A
- Fundamental
- Price
- ELVA $6.77
- MIST $1.95
- Analyst Decision
- ELVA Strong Buy
- MIST Strong Buy
- Analyst Count
- ELVA 4
- MIST 3
- Target Price
- ELVA $6.13
- MIST $6.33
- AVG Volume (30 Days)
- ELVA 516.0K
- MIST 1.1M
- Earning Date
- ELVA 08-13-2025
- MIST 11-11-2025
- Dividend Yield
- ELVA N/A
- MIST N/A
- EPS Growth
- ELVA 58.59
- MIST N/A
- EPS
- ELVA 0.03
- MIST N/A
- Revenue
- ELVA $54,875,000.00
- MIST N/A
- Revenue This Year
- ELVA $46.40
- MIST N/A
- Revenue Next Year
- ELVA $46.08
- MIST N/A
- P/E Ratio
- ELVA $248.75
- MIST N/A
- Revenue Growth
- ELVA 10.88
- MIST N/A
- 52 Week Low
- ELVA $1.73
- MIST $0.63
- 52 Week High
- ELVA $7.08
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- ELVA 70.59
- MIST 64.72
- Support Level
- ELVA $5.76
- MIST $1.75
- Resistance Level
- ELVA $6.23
- MIST $2.06
- Average True Range (ATR)
- ELVA 0.41
- MIST 0.09
- MACD
- ELVA 0.02
- MIST 0.02
- Stochastic Oscillator
- ELVA 77.37
- MIST 69.44
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).